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The data described here provide a systematic performance evalua-
tion of popular data-dependent (DDA) and independent (DIA) mass
spectrometric (MS) workﬂows currently used in quantitative
proteomics. We assessed the limits of identiﬁcation, quantiﬁcation
and detection for each method by analyzing a dilution series of 20
unmodiﬁed and 10 phosphorylated synthetic heavy labeled refer-
ence peptides, respectively, covering six orders of magnitude in
peptide concentration with and without a complex human cell
digest background. We found that all methods performed very
similarly in the absence of background proteins, however, when
analyzing whole cell lysates, targeted methods were at least 5–10
times more sensitive than directed or DDA methods. In particular,
higher stage fragmentation (MS3) of the neutral loss peak using a
linear ion trap increased dynamic quantiﬁcation range of some
phosphopeptides up to 100-fold. We illustrate the power of this
targeted MS3 approach for phosphopeptide monitoring by success-
fully quantifying 9 phosphorylation sites of the kinetochore and
spindle assembly checkpoint component Mad1 over different cell
cycle states from non-enriched pull-down samples. The data are
associated to the research article ‘Evaluation of data-dependent andvier Inc. This is an open access article under the CC BY license
midt).
M. Bauer et al. / Data in Brief 5 (2015) 297–304298data-independent mass spectrometric workﬂows for sensitive
quantiﬁcation of proteins and phosphorylation sites' (Bauer et al.,
2014) [1]. The mass spectrometry and the analysis dataset have been
deposited to the ProteomeXchange Consortium (http://proteomecen
tral.proteomexchange.org) via the PRIDE partner repository with the
dataset identiﬁer PXD000964.
& 2015 The Authors. Published by Elsevier Inc. This is an open access
article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Speciﬁcations tableSubject area Biology, chemistry
More speciﬁc
subject areaPhosphoproteomics and mass spectrometry (MS)Type of data MS-data, Tab-delimited and Microsoft Excel tables
How data was
acquiredEasy-nLC liquid chromatography system coupled to either a LTQ Orbitrap Velos or a TSQ Vantage
mass spectrometer (all Thermo Scientiﬁc)Data format Raw (.raw), mgf peak lists (.mgf), transition lists and Skyline processed ﬁles (.csv and.xlsx)
Experimental factors Sensitivity assessment of different LC–MS approaches using dilution series experiments and
application of the most sensitive MS method to quantify MAD1 phosphorylation sites during cell
cycle.Experimental
featuresDifferent dilution series of peptides were analyzed using one dimensional liquid chromatography
separation and different data-dependent and independent mass spectrometry workﬂows to assess
their limits of quantiﬁcation. The most sensitive method was applied to monitor phosphorylation
site changes in immunopuriﬁed MAD1 across different cell cycle stages using thymidine and
nocodazole treatment.Data source location Basel, Switzerland
Data accessibility The data are available via ProteomeXchange with identiﬁer PXD000964 http://proteomecentral.
proteomexchange.org/cgi/GetDataset?ID=PXD000964Value of the data Assessment of detection and quantiﬁcation limits for data-dependent, directed and targeted mass
spectrometric workﬂows Individual MS workﬂow evaluation for unmodiﬁed and phosphorylated peptides
 The ability to monitor low abundant peptides and phosphorylation sites is demonstrated by
quantitation of phosphorylation sites from immunopuriﬁed MAD1 protein during the cell cycle
without the need for phosphopeptide enrichment steps. Data can be employed to evaluate and improve identiﬁcation and quantiﬁcation capability of
proteomics software tools to monitor low abundant peptides/proteins and protein modiﬁcations.
1. Data, experimental design, materials and methods
1.1. Experimental design
The general aim of this study was to assess the capabilities of recently established data-dependent
(DDA) and independent (DIA) LC–MS strategies [2] in terms of sensitivity and linear relative
quantiﬁcation range for a variety of different peptides in the presence and absence of a complex
analytical background (see Fig. 1). Therefore, we prepared serial dilutions of two different peptide
Fig. 1. Experimental setup for the determination of quantiﬁcation and detection limits for data-dependent and independent
quantitative mass spectrometry workﬂows.
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covering a concentration range of 6 and 5 orders, respectively (referred to as neat samples). To assess
analytical performance under a more realistic scenario, we prepared the same dilution series with a
complex human digest spiked into each sample (referred to as complex samples). This allowed us to
precisely determine the impact of the analytical background on limit of detection (LOD),
quantiﬁcation (LOQ) and identiﬁcation (LOI) for each peptide and MS-approach applied in this study.
The four dilution series were analyzed in duplicate using the following DDA and DIA MS-approaches.
(i) In DDA, only peptides of the highest intensities in the acquired survey scans are selected for MS-
sequencing while many other peptides of sufﬁcient intensity for identiﬁcation pass through the
instrument to remain unidentiﬁed. (ii) Directed LC–MS/MS strategy (also termed inclusion mass list
driven, INL) that attempts to overcome this limitation by directing MS-sequencing to the precursors of
interest independent of their MS-intensities using an inclusion mass list. Albeit several thousands of
peptides can be analyzed by this approach, a drawback is the necessity to detect the precursor ions in
the MS1 survey scans to trigger fragmentation. (iii) Targeted LC–MS/MS methods (selected reaction
monitoring (SRM) and pseudo-selected reaction monitoring (pSRM, like SRM, but a full MS/MS-scan is
acquired) that directly fragment selected peptide ions and use the corresponding fragment ions for
identiﬁcation and quantiﬁcation. We analyzed each sample by SRM using a triple quadrupole (QqQ)
MS and by pSRM using collision induced dissociation (CID, ion detection in the linear ion trap (LIT))
based fragmentation. For phosphopeptide analysis, we additionally carried out higher energy collision
dissociation (HCD, ion detection in the orbitrap) and neutral loss MS2/MS3 CID fragmentation in the
LIT. All peptides were quantiﬁed using Skyline [3,4] and fragment spectra were identiﬁed by database
searching. Finally, we generated dilution proﬁle correlations for each peptide and MS-method and
applied an established algorithm [3,4] to determine linear quantiﬁcation ranges as well as
identiﬁcation, quantiﬁcation and detection limits.
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HeLa S3 were cultured in Dulbecco's modiﬁed Eagle's medium (DMEM, Invitrogen, Carlsbad, CA)
supplemented with 10% heat-inactivated fetal calf serum (FCS) and penicillin–streptomycin (100 IU/
ml and 100 μg/ml, respectively, GIBCO) at 37 1C in a 5% CO2 atmosphere in a humidiﬁed incubator. 107
cells were collected by centrifugation and cell pellets washed twice with PBS. Cells were lysed
in 200 ml lysis buffer (8 M Urea, 0.1% RapiGest, 0.1 M ammoniumbicarbonate) using strong ultra-
sonication and total protein concentration determined by BCA assay (Thermo Scientiﬁc) according to
the manufacturer's instructions. Then, proteins were reduced with 5 mM TCEP for 60 min at 37 1C and
alkylated with 10 mM iodoacetamide for 30 min in the dark at 25 1C. After quenching the reactions
with 12 mM N-acetyl-cysteine, protein samples were digested by incubation with sequencing-grade
Lys-C (1/200, w/w; Wako) for 4 h at 37 1C. Samples were diluted 1:4 with 0.1 M ammoniumbicarbo-
nate buffer to reduce urea concentration to 1.6 M and digestion continued by adding modiﬁed trypsin
(1/50, w/w; Promega, Madison, Wisconsin) over night at 37 1C. Subsequently, peptides were desalted
on C18 reversed-phase columns according to the manufacturer's instructions (SEP-PAK Vac 3cc
500 mg, Waters), dried under vacuum and stored at 80 1C until further use.
1.3. Generation of serial dilution mixtures
We took advantage of an ongoing parallel study aiming at the absolute quantiﬁcation of centrosomal
proteins and employed the chemically synthesized 20 heavy labeled reference peptides (AQUA grade,
Thermo Scientiﬁc, Table S1) as spike in standards for our systematic quantitative evaluation of different
MS approaches. In this study, for each of the 10 centrosomal proteins of interest the two full tryptic
peptides with the highest MS-intensities lacking any missed cleavages were selected as reference
peptides. Subsequently, a mixture comprising equal concentrations of all peptides was prepared and a
dilution series generated using 10-fold steps starting from 0.5 pmol/ml to 0.5 amol/ml. To minimize
peptide losses during pipetting and storage, low binding tips (Axygen) and glass vials (VWR
International) were applied for all sample preparation steps. Next, the same dilution series was
prepared adding the human cell digest sample at a concentration of 0.5 ug/ml to all samples.
In a second dilution experiment, we employed a standard mixture containing 10 singly and doubly
phosphorylated peptides in equal amounts (MS PhosphoMix 1 Heavy, Sigma-Aldrich, Table S1) and
prepared the same two dilution series (with and without a human cell digest) as described above,
starting from 50 fmol/ml to 0.5 amol/ml. 2 ml of each sample were subjected to LC-MS analysis.
1.4. Mass spectrometric analysis
1.4.1. Data-dependent acquisition (DDA) LC–MS/MS
Peptides were separated on a RP-LC column (75 μm20 cm) packed in-house with C18 resin (Magic
C18 AQ 3 μm; Michrom BioResources, Auburn, CA, USA) using a linear gradient from 95% solvent A (98%
water, 2% acetonitrile, 0.15% formic acid) and 5% solvent B (98% acetonitrile, 2% water, 0.15% formic acid)
to 30% solvent B over 40 min at a ﬂow rate of 0.2 μl/min. Each survey scan acquired in the Orbitrap at
60,000 FWHMwas followed by 20 MS/MS scans of the most intense precursor ions in the linear ion trap
with enabled dynamic exclusion for 20 s. Charge state screening was employed to select for ions with at
least two charges and rejecting ions with undetermined charge state. The normalized collision energy
was set to 32% and one microscan was acquired for each spectrum. Collision induced dissociation was
triggered when the precursor exceeded 100 ion counts. The ion accumulation time was set to 300 ms
(MS) and 50 ms (MS/MS). All samples were measured in triplicates. Phosphopeptide analysis was carried
out as described above with the following modiﬁcation: each survey scan was followed by 10 MS/MS
scans of the most intense precursor ions in the linear ion trap with enabled multistage activation.
1.4.2. Directed (INL) LC–MS/MS
For directed LC–MS/MS two inclusion mass lists comprising the calculated ion masses of the
observed precursor ions of either 20 unmodiﬁed (Table S2) or 10 phosphorylated (Table S3) peptides
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out using the same settings as for DDA analysis with a few modiﬁcations; mono-isotopic precursor
selection was disabled and peaks with unassigned charge states were not rejected. This helped to
trigger more MS-sequencing attempts. Furthermore, ion accumulation time for MS2 scans was set to
100 ms.
1.4.3. Pseudo-selected reaction monitoring (pSRM) LC–MS/MS
PRM was carried out in the linear ion trap (LIT) (CID) and Orbitrap (HCD), respectively. For both
experiments, the peptides and their modiﬁcations were imported into the Skyline software (version 2.4)
(https://skyline.gs.washington.edu/labkey/wiki/home/software/Skyline/page.view?name=default) [4,5].
The precursor ion masses were automatically calculated and the masses of all observed precursor ions
exported as an instrument method ﬁle (Tables S2 and S3). For pSRM-CID-MS2 ion accumulation time
was set to 10 ms and the mass selection window was set to 1 Da. The collision energy was set to 35%
and activation time was 10 ms. Fragment ions were scanned from the lowest possible m/z to 2000 Th.
For pSRM-HCD, MS2 spectra were acquired at a resolution of 7500 (FWHM at 400 m/z), ion
accumulation time was 50 ms, mass selection window was set to 2 Da, collision energy of 35%,
activation time of 100 ms and the measured mass range was from 100 Th to 2 times the precursor mass.
Additionally, corresponding charge states were set in the instrument HCD fragmentation method. For
pSRM-CID-MS3 analysis, the neutral loss masses were manually calculated and added to the pSRM-CID-
MS2 instrument method. Here, to increase sensitivity, the mass selection window was set to 2 Da for
MS2/MS3 ion isolation and an ion accumulation time of 50 ms was applied.
1.4.4. SRM LC–MS/MS (on triple quadrupole instrument)
Data derived from a spectral library generated based on acquired HCD spectra of the standard
peptide mix from the PRM-HCD experiment were imported into the Skyline program (version 2.4) to
extract the corresponding fragment ion masses and precursor ion masses (transitions). After collision
energy optimization, the ﬁve most suited transitions per peptide were selected and traced on a triple
quadrupole mass spectrometer (QqQ, TSQ Vantage, Thermo Scientiﬁc) connected to an electrospray
nano ion source and Easy nano-LC system (both Thermo Scientiﬁc) using the same setting as used for
DDA LC–MS analysis. Cycle time was set to 2 s resulting in a dwell time of 20 ms per transition. The
transition lists with optimized collision energies comprising the 20 unmodiﬁed and 10 phosphopep-
tides are provided as supplemental Tables S4 and S5, respectively.
1.5. Data processing
1.5.1. Peptide quantiﬁcation/determination of quantiﬁcation limits
All raw ﬁles were loaded into the Skyline software tool (version 2.4) to generate extracted ion
chromatograms of the precursor (up to 5) or fragment (up to 10) ions. The mass windows were
adjusted to the resolution applied in the corresponding MS method. For PRM-CID methods, a mass
window of 0.4 Da was applied. To make the PRM-CID-MS3 data ﬁles readable for the Skyline software,
we converted the raw ﬁles to mzXML format using MM-conversion tool (version 3.9, www.
massmatrix.org) and replaced the neutral loss masses used for MS3 by the corresponding original
precursor ion masses using an in-house Perl script (available upon request). All integrated peak/
transitions were manually inspected and corrected or removed, if required. The integrated and
quantiﬁed peak/transitions obtained for the different methods and samples are listed in Tables S6–14.
Finally, we generated dilution proﬁle correlations and applied an established algorithm [3] to
determine LOQ and LOD values as well as linear correlations (Pearson's correlation coefﬁcient (R2)
from highest concentration to LOQ) for each MS-method and peptide analyzed.
1.5.2. Determination of identiﬁcation limits
All raw ﬁles acquired by DDA, INL and pSRM for the dilution curve samples of unmodiﬁed peptides were
converted to mgf-format using the MM-conversion tool (version 3.9, www.massmatrix.org) and searched
against a decoy (consisting of forward and reverse protein sequences) human SwissProt database (download
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(Matrix Science, version 2.4). The search parameters were set as follows; full tryptic speciﬁcity was required
(cleavage after lysine or arginine residues unless followed by proline), up to two missed cleavages were
allowed, carbamidomethyl (C) was set as ﬁxed modiﬁcation, oxidation (M), Label: 13C(6)15N(2) (K) and
Label: 13C(6)15N(4) (R) as variablemodiﬁcation,10 ppmprecursormass tolerance and 0.6 (0.02) Da fragment
mass tolerance for CID (HCD) tandemmass spectra. After importing the data to the Scaffold software (http://
www.proteomesoftware.com, version 4.2.1) the FDR rate was set to o1% for MS/MS-spectra identiﬁcations
by the Scaffold Local FDR algorithm based in the number of decoy hits. All identiﬁed MS/MS-spectra in the
dilution curve experiment for DDA, INL and pSRM are available as supplement data (Tables S15–S17).
1.6. Monitoring of Mad1 phosphorylation sites
1.6.1. Cell culture, synchronization and kinase inhibitors
HeLa S3 were cultured as described above. Cell cycle arrest in S-phase was induced by thymidine
(2 mM, Sigma-Aldrich) treatment for 24 h. For MS analysis of mitotic cell cycle stages, cells were
released from thymidine and arrested in mitosis before harvesting. Mitotic arrest in prometaphase
was induced by Nocodazole (0.5 μg/mL, Sigma-Aldrich) treatment for 14 h after thymidine release.
Mitotic cells were collected by mitotic shake-off. Mitotic arrest in metaphase was induced by addition
of the proteasome inhibitor MG132 (10 μM, Calbiochem) for 2 h, 10 h after thymidine release.
1.6.2. Cell extracts and immunoprecipitations
For preparing extracts, HeLa S3 cells were washed once with ice-cold PBS, and resuspended in ice-
cold lysis buffer (20 mM Tris, pH 7.4, 150 mM NaCl, 0.5% IGEPAL CA-630, 1 mM DTT, 30 μg/ml RNAse,
30 μg/ml DNAse, protease inhibitor cocktail (Roche, 1 EDTA- free tablet for 10 ml lysis buffer) and
phosphatase inhibitors cocktail (cocktails 2 and 3; Sigma- Aldrich) and incubated for 30 min on ice.
After cell lysis, suspensions were cleared by centrifugation at 14,000 rpm for 15 min. Immuno-
puriﬁcation of endogenous Mad1 was performed using 50 μl of solid Afﬁ-Prep protein G matrix beads
(Bio-Rad Laboratories) chemically cross-linked to 1 μg/μl of antibody against 1–2 mg of clariﬁed cell
lysate for 2 h at 4 1C. Afterwards the resin was washed with lysis buffer followed by washing with
HNN buffer (50 mM Hepes pH7.5, 150 mM NaCl, 5 mM EDTA, 50 mM NaF). Proteins were eluted with
100 mM glycine pH 2.8, neutralized by the addition of Tris buffer (pH 8,0), reduced, alkylated,
enzymatically cleaved and prepared for MS analysis as described above. For generating a
comprehensive phosphorylation site map of Mad1, immune-puriﬁed proteins obtained from 10 (S-
phase) and 15 (prometaphase and metaphase) 15 cm dishes were pooled, split in two aliquots and
subjected to the two different phosphopeptide enrichment strategies described below. For monitoring
of Mad1 phosphorylation sites, sufﬁcient protein amounts could be obtained from 1 (S-phase) and 2
(prometaphase and metaphase) 15 cm dishes. After sample preparation, the peptide samples were
dissolved in 40 ml of 0.1% formic acid containing 125 fmol/μl of each heavy labeled phosphopeptides.
1.6.3. Phosphopeptide enrichment (TIO2)
30 μl of titanium dioxide beads (100 mg/ml, Titansphere, GL Sciences Inc, Japan) were placed on
self-made GELoader tips (Eppendorf) plugged with a piece of C8 material (Empore, 3M, 3M Empore C8
and C18 disks, 2214-C8, Bioanalytical Technologies,St. Paul, MN). The columns were washed with
water (HPLC grade, Sigma-Aldrich), methanol and a solution of 80% ACN (Acetonitrile), 2.5% TFA
(Triﬂuoroacetic acid), saturated with phthalic acid. Digested and dried peptides were reconstituted in
80% ACN, 2.5% TFA, saturated with phtalic acid and loaded on the micro-columns. To allow maximal
binding of phosphorylated peptides to the titanium dioxide beads the peptide-bead mixture was
incubated for 10 min, then slowly passed through and applied for two additional times. The micro-
columns were subsequently washed with a mixture of 80% ACN and 2.5% TFA, saturated with phthalic
acid, a mixture of 80% ACN, 20% water and 0.1% TFA and ﬁnally with 0.1% TFA. Phosphorylated
peptides bound on the TiO2 were eluted with 0.3 M ammonium hydroxide solution. Phosphopeptide
enriched eluates were immediately acidiﬁed with 2 M HCl and 5% TFA, desalted and puriﬁed on C18
Microspin columns (Harvard Apparatus) and dried in a SpeedVac concentrator.
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PHOS-Select™ Iron Afﬁnity Gel beads (Sigma-Aldrich) and dried peptides were re-suspended in 30%
acetonitrile/250 mM ethanol. IMAC beads and peptides were shaked at room temperature at 1400 rpm for
2 h. Subsequently samples were loaded three times in a constricted GELoader tip and washed four times
with 30% acetonitrile/250 mM ethanol. Phosphorylated peptides were eluted using 50 mM Na2HPO4/NH3
(pH 10.0), acidiﬁed with 100% ethanol and 10% TFA (pHo3.5), desalted and passed to LC–MS/MS analysis.
1.6.5. Generation of a Mad1 phosphorylation site catalog from phosphopeptide enriched samples
1 mg of total phosphopeptides were subjected to DDA LC–MS/MS using HCD and CID with enabled
multistage activation fragmentation as speciﬁed above. Acquired raw ﬁles were database searched
using Mascot and Scaffold software as described above with the following parameter modiﬁcation:
oxidation (M), Label: 13C(6)15N(2) (K), Label: 13C(6)15N(4) (R) and phosphorylation (S, T, Y) were set
as variable modiﬁcation. The identiﬁed proteins, peptides and MS/MS-spectra (Tables S18–S20) were
ﬁltered to a FDR of 1% according to the Scaffold Local FDR algorithm based in the number of decoy hits.
A list of all MS/MS-spectra assigned to Mad1 phosphopeptides is shown in Table S21 and a summary
list comprising all identiﬁed Mad1 phosphorylation sites is illustrated in Table 1. Protein probabilities
were assigned by the Protein Prophet program. Proteins that contained similar peptides and could not
be differentiated based on MS/MS analysis alone were grouped to satisfy the principles of parsimony.
Proteins sharing signiﬁcant peptide evidence were grouped into clusters. The location of the
phosphorylated residues was automatically assigned by MASCOT (score410).
1.6.6. Mad 1 phosphorylation site monitoring
Heavy labeled reference peptides were synthesized for all identiﬁed phosphopeptides of the Mad1
proteins. For precise quantitation of the single serine phosphorylation sites at positions S484, S485,
S486 and S490, we ordered all possible mono-phosphorylated versions of the corresponding heavy
reference peptide (SQSSSAEQSFLFSR). All different phosphopeptide sequences and modiﬁcations
together with the identiﬁed MS/MS-spectra from the previous phosphorylation catalog experiment
were imported into the Skyline software (Version 2.4) to set up a pSRM method to monitor allTable 1











27.71 SLNNFISQR 2þ S16 Yes Mps1, Plk1
34.77 IQELQASQEAR 2þ S214 Yes Mps1, Plk1, ATM
kinase
33.02 DLEQKLSLQEQDAAIVK 3þ S233 No
41.78 LSLQEQDAAIVK 2þ S233 No
46.69 AILGSYDSELTPAEYSPQLTR 3þ S428 Yes Mps1, Cdk1
54.81 AILGSYDSELTPAEYSPQLTR 2þ S428 Yes Mps1, Cdk1
83.7 SQSSSAEQSFLFSR 2þ S484 No
56.79 SQSSSAEQSFLFSR 2þ S485 No
68.94 SQSSSAEQSFLFSR 2þ S486 No
72.63 SQSSSAEQSFLFSR 2þ S490 Yes Mps1, Plk1
31.74 SQSSSAEQSFLFSREEADTLR 3þ S494 No
28.07 EEADTLR 2þ T500 No
21.74 LKVEELEGERSR 3þ S513 Yes Mps1, (Plk1)
25.55 LKVEELEGERSR 2þ S513 Yes Mps1, (Plk1)
24.27 VEELEGERSR 2þ S513 Yes Mps1, (Plk1)
22.61 ALQGDYDQSR 2þ S538 No Mps1, (Plk1)
25.25 LREDHSQLQAECER 3þ S562 Yes Mps1, (Plk1)
a Best ion score determined by the Mascot search engine. A detailed list of all identiﬁed MS/MS-spectra is shown in Tables
S20 and S21.
b Adopted from www.phosphosite.org (20.05.14).
c Predicted consensus motif for Mps1, Plk1, Cdk1 and ATM/ATR kinase.
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the best transitions for each peptide. Due to their higher selectivity and lower noise levels, transitions
originating from MS3 scans were preferred, if available. Phosphopeptides were quantiﬁed using the
Skyline tool and the same parameters as described above. The quantitative results including
normalization, ratio determination and statistical analysis are summarized in Tables S22 and S23.
For the determination of phosphorylation site stoichiometries and to compensate variations in
Mad1 concentrations, additional label-free quantiﬁcation experiments of the same samples were
carried out. 1ug of peptides were subjected to DDA LC–MS/MS analysis using CID with enabled
multistage activation fragmentation and the same LC and MS settings as speciﬁed above. The LC–MS
Progenesis software (Version 4.1.4832.42146) in combination with the Mascot database search tool
(Version 2.4) was employed to identify and quantify unmodiﬁed and modiﬁed Mad1 peptides using
the same database search parameters for phosphopeptides as described above. Importantly, the
Progenesis software was set that only non-conﬂicting peptides with speciﬁc sequences for single
proteins in the database were employed for quantiﬁcation. The results were further statically
validated by our in-house software tool SafeQuant [6] (available upon request). All identiﬁed and
quantiﬁed peptides are listed in Table S24. Differences in Mad1 concentrations in the samples were
normalized using the sum of all MS-intensities generated from Mad1 peptides. The corresponding
normalization factors using the ﬁrst sample as base are displayed in Table S23. The data ﬁle names of
LC–MS runs of all samples analyzed in this study are shown in Table S25.Acknowledgments
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